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ArticleMacromolecular crowding modulates a-synuclein
amyloid fiber growthIstvan Horvath,1 Ranjeet Kumar,1 and Pernilla Wittung-Stafshede1,*
1Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, SwedenABSTRACT The crowdedness of living cells, hundreds of milligrams per milliliter of macromolecules, may affect protein folding,
function, and misfolding. Still, such processes are most often studied in dilute solutions in vitro. To assess consequences of the
in vivomilieu, we here investigated the effects of macromolecular crowding on the amyloid fiber formation reaction of a-synuclein,
the amyloidogenic protein in Parkinson’s disease. For this, we performed spectroscopic experiments probing individual steps of
the reaction as a function of the macromolecular crowding agent Ficoll70, which is an inert sucrose-based polymer that provides
excluded-volume effects. The experiments were performed at neutral pH at quiescent conditions to avoid artifacts due to shaking
andglass beads (typical conditions fora-synuclein), usingamyloid fiber seeds to initiate reactions.Wefind that both primary nucle-
ation and fiber elongation steps during a-synuclein amyloid formation are accelerated by the presence of 140 and 280 mg/mL Fi-
coll70. Moreover, in the presence of Ficoll70 at neutral pH, secondary nucleation appears favored, resulting in faster overall a-
synuclein amyloid formation. In contrast, sucrose, a small-molecule osmolyte and building block of Ficoll70, slowed down a-syn-
uclein amyloid formation. The ability of cell environments tomodulate reaction kinetics to a large extent, such as severalfold faster
individual steps in a-synuclein amyloid formation, is an important consideration for biochemical reactions in living systems.SIGNIFICANCE Proteins normally function in cells crowded by many different macromolecules. But sometimes, specific
proteins begin to assemble with identical proteins into so-called amyloid fibers. Amyloid formation is a process toxic to cells
that underlies many neurodegenerative diseases, for example, Parkinson’s disease. To eventually find cures for such
disorders, we need a molecular-mechanistic understanding of the assembly process resulting in amyloid fibers. It is not
enough to investigate such reactions in dilute solutions in test tubes, one must also consider potential effects caused by the
crowded cell milieu. Here, we use biophysical methods to reveal that macromolecular crowding, mimicking steric
restrictions in cells, accelerate individual steps and promote secondary nucleation in the amyloid formation process of the
Parkinson’s disease protein a-synuclein.INTRODUCTION
The intracellular environment is highly crowded, with an es-
timate of up to 400mg/mLmacromolecules (proteins, lipids,
and polysaccharides), corresponding to a volume occupancy
of up to 40% (1,2). High concentrations of macromolecules
restrict the available molecular space by their mutual impen-
etrability and repulsive interactions, often termed excluded-
volume effect. The excluded-volume effect is accompanied
by increased opportunities for nonspecific (chemical or
‘‘soft’’) interactions, increased (heterogeneous) viscosity,
reduced macromolecule dynamics, as well as changes in sol-
vent polarity and water activity, which in total describe theSubmitted March 10, 2021, and accepted for publication June 28, 2021.
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creativecommons.org/licenses/by-nc-nd/4.0/).macromolecular crowding effect (3,4). The excluded-vol-
ume effect is an entropic force in which (because of steric re-
strictions) compact and assembled protein species are
favored (1,5–8). Many in vitro studies of excluded-volume
effects using so-called macromolecular crowding agents,
for example, the inert sugar-based polymers Ficoll and
dextran (4,9), on protein folding and stability have shown
increased folded-state stability and slower unfolding reac-
tions in the presence of macromolecular crowding agents
(9–12). Macromolecular crowding typically favors protein-
protein interactions because assembled states will reduce
the volume occupancy and number of species in solution.
However, the effect on reaction kinetics will depend on
conformational changes and rate-limiting steps. Here, amy-
loid formation is interesting because this assembly process
involves multiple steps and protein-conformational changes
(13). Amyloid fibrils are biological polymers composed of
Crowding effects on amyloid kineticsmonomeric protein units noncovalently assembled through
b-strands arranged perpendicularly to the fibril axis, thereby
forming a cross-b structure (14).Many proteins can form am-
yloid fibrils at certain solvent conditions (13), but this process
is mostly connected to human diseases such as Alzheimer’s
disease and Parkinson’s disease (PD) (15–17).
PD is the second most common neurodegenerative disor-
der and the most frequent movement disorder today and
there is only symptomatic treatment (18,19). Assembly of
the protein a-synuclein (aS) into amyloid fibrils has been
linked to the molecular basis of PD, with aS amyloids being
the major content of pathological neuronal inclusions, the
Lewy bodies, found in PD patient brain cells (20–22). In
accord, duplications, triplications, and point mutations in
the aS gene are linked to familial PD cases (23). In solution,
aS is an intrinsically disordered polypeptide, but it adopts
significant a-helical structure when interacting with lipid
vesicles. Despite the key role of aS in PD, its exact functions
remain unknown but appear related to synaptic vesicle
release and trafficking, regulation of enzymes and trans-
porters, and control of the neuronal apoptotic response
(24–26). Amyloid formation aS (and other amyloidogenic
proteins) proceeds via at least two reaction steps: primary
nucleation and elongation of fibrils (14,27). The process
is, in addition, typically catalyzed by secondary processes
including secondary nucleation (14,27) and, in some cases,
fibril fragmentation (28). It is reported that for aS, primary
processes dominate at physiological pH, whereas at lower
pH, secondary processes become more important (29).
To eventually cure or prevent PD, we need to understand
how and when aS amyloid formation takes place in its natural
environment invivo.Afirst step toward this is to determine the
effects of macromolecular crowding on the aggregation pro-
cess of aS in vitro. To date, however, most aS amyloid forma-
tion studies are performed in diluted buffer solutions.We here
addressed this knowledge gap by carefully probing the effects
of excluded volume on the molecular steps involved in aS am-
yloid formation. To create excluded-volume conditions, we
have used the macromolecular crowding agent Ficoll70
(70 kDa), which is a sucrose-based branched polymer often
used for this purpose (30,31). Although there may be excep-
tions (32), Ficoll70 has been shown to only provide steric,
excluded-volume effects without chemical interactions with
proteins (9,12,33). In contrast to earlier reports of crowding ef-
fects on aS aggregation (34–38), we have characterized the
excluded-volume effect on fiber-seeded experiments to elim-
inate issues with shaking and glass beads.MATERIALS AND METHODS
Materials
Human aS was expressed and purified as described in (39). Molecular
biology grade Ficoll70 (Sigma-Aldrich, St. Louis, MO) stock solutions
were prepared in Tris-buffered saline (TBS; 0.05 M Tris-HCl buffer
(pH 7.6 (pH 7.4 at 37C)) with 0.15M NaCl, 93318; Sigma-Aldrich) buffer,the pH of the solution was adjusted to 7.6 after the Ficoll70 was dissolved.
All solutions used were cleared with 0.22-mm filtering.Amyloid formation
Before aS aggregation assays, size-exclusion chromatography was per-
formed on freshly thawed aS protein solutions using a Superdex 75 10/
300 (Cytiva, Uppsala, Sweden) gel filtration column in TBS buffer to ensure
that the starting material was monomeric. The aggregation assay in shaking
conditions were conducted as described previously (40,41): aS amyloid for-
mation reactions were conducted in 96-well, half-area transparent-bottom
plates with a nonbinding surface (CLS3881; Corning, Corning, NY) with
one 2-mm glass bead in each well using a plate reader and incubator instru-
ment (Fluorostar Optima; BMG Labtech, Ortenberg, Germany). Measure-
ments were performed in TBS (pH 7.4) with 0.15 M NaCl buffer in the
presence of 20 mM Thioflavin T (ThT; T3516; Sigma-Aldrich), 2 mM
EDTA, and 0.005% sodium azide at 37C using 200 rpm agitation for
5 min during 20-min measurement cycles; fluorescence was measured
from the bottom side of the plate, and the aS concentration was 50 mM.
For measurements in quiescent conditions, the 5-min agitation was omitted
from the protocol, and no glass beads were used in the wells. Samples were
typically incubated for 120 h, and fluorescence was measured every 20 min.
ThTwas excited at 440 nm, and emission was recorded at 480 nm. All ThT-
containing aS aggregation experiments were performed in quadruplicate at
each time (on the same plate), and the experiments were repeated three in-
dependent times (different plates).aS seed preparation
Amyloid fiber seeds of aS were prepared by incubating 250 mM aS in TBS
with 5% premade fibrils (prepared using agitation in plate reader as
described in the aggregation assays) for 1 week at 37C. To obtain short fi-
ber seeds, an aggregated sample was sonicated for 10 s using a probe son-
icator (stepped microtip and Ultrasonic Processor Sonics Vibra-Cell; Sonics
& Materials, Newtown, CT) at an amplitude of 20% and an alternating cy-
cle of 5 s on and 5 s off. The aggregated material was characterized by
atomic force microscopy (AFM) showing long amyloid fibers (>5 mm)
for the nonsonicated and short amyloid fibers (<1 mm) for the sonicated
protein samples. The fiber seed solutions were aliquoted, flash frozen in
liquid nitrogen, and stored in 150C until usage.AFM
Samples from aggregation reactions were diluted into Milli-Q water (10–20
times; MilliporeSigma, Burlington, MA) and deposited on freshly cleaved
mica. After 10 min, the mica was rinsed with filtered Milli-Q water (Milli-
poreSigma) and dried under a gentle nitrogen stream. Images were recorded
on an NTEGRA Prima setup (NT-MDT, Moscow, Russia) using a gold-
coated single crystal silicon cantilever (NT-MDT, NSG01, spring constant
of 5.1 N/m) and a resonance frequency of 180 kHz. Here, 512  512-
pixel images were acquired with a 0.5-Hz scan rate. Images were analyzed
using the WSxM 5.0 software. For each sample, images were taken in at
least three different 50  50-mm areas; the images shown in the figures
are representatives for each sample. For the analysis of the oligomer sizes,
flooding analysis was used; particles larger than 2 nm were included in the
analysis.Circular dichroism spectroscopy
Far-UV circular dichroism (CD) spectra of aS (5 mM) were recorded on a
Chirascan spectropolarimeter (Applied PhotoPhysics, Leatherhead, UK)
in 10 mM phosphate buffer in the absence and presence of Ficoll70. CD
spectra between 250 and 190 nm were collected in a quartz cuvette (pathBiophysical Journal 120, 3374–3381, August 17, 2021 3375
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ning speed of 50 nm/min. Three individual spectra were acquired and aver-
aged for each condition. The CD spectra of the respective Ficoll70 solutions
were subtracted from the spectra measured on the protein.Kinetic data analysis
All fluorescence data were normalized before analysis. For the determina-
tion of the initial rates in seeded (with sonicated seeds) conditions, linear
fits were applied to fluorescence data points in the first 1–2 h of the aggre-
gation reactions (before curvature was noted). Reaction half-times were
determined as the time point in which the fluorescence signal exceeded
0.5 (i.e., halfway to maximal intensity) in the normalized ThT data. For
analysis of seeded reactions (sonicated seeds, initial rates; nonsonicated
seeds, half-times), data from 12 individual replicates (four replicas per-
formed in three independent experiments) were averaged (except for 2.5,
5, and 20% seeds in 280-mg/mL Ficoll70 conditions in which only nine rep-
licates were used for the averages). Error bars denote standard deviation in
the initial rate and half-time plots, considering all replicates at each
condition.Viscosity measurements
The bulk (macro)viscosities of Ficoll70 and sucrose solutions were deter-
mined using a Discovery HR-3 rheometer from TA Instruments (New
Castle, DE). The geometry was a cone plate with a 40-mm diameter,
one-degree angle, and 26 mm of a gap. The viscosity was recorded at
T ¼ 37C between shear rates of 0.01 and 1000 s1. The temperature
was controlled using a Peltier plate. The viscosity profiles showed a New-
tonian profile (as expected for this sort of samples) with viscosity values of
3.91 5 0.07 cP for 140 mg/mL Ficoll 70, 17.6 5 2.28 cP for 280 mg/mL
Ficoll70, and 4.19 5 0.15 cP for 550 mg/mL sucrose.RESULTS AND DISCUSSION
Shaking conditions not useful
Aggregation of aS into amyloid fibers in vitro is often
probed using monomeric aS that is placed at 37C in a plate
reader with shaking and glass beads to speed up the reac-
tion. At these conditions, aS amyloid formation, monitored
in real time by ThT fluorescence, shows a sigmoidal curve
in which there is first a lag time, followed by a growth
phase at around 20 h (for 50 mM), and then a plateau is
reached. Initial experiments, adding Ficoll70 to such reac-
tions, revealed that this is not a useful setup for crowding
experiments. Because Ficoll70 increases the viscosity, it
will affect the movement of the glass beads. We found
that at very high Ficoll70 (280 mg/mL), aS aggregation ap-
peared faster, but at lower Ficoll70 (140 mg/mL), aggrega-
tion of aS was reduced, as compared with in buffer, with
this experimental setup (Fig. S1). To avoid the issues
with shaking and glass beads, we turned to quiescent con-
ditions without glass beads. At nonshaking conditions, aS
on its own will not aggregate within our typical experi-
mental time frame of up to 140 h. However, by the addition
of amyloid fiber seeds, the slow primary nucleation is by-
passed, and amyloid formation is detected immediately
(see below).3376 Biophysical Journal 120, 3374–3381, August 17, 2021Effect of Ficoll70 on nonseeded amyloid
formation reaction
The presence of Ficoll70 does not affect the disordered
far-UV CD signal of aS monomers in solution (Fig. S1 D).
At conditions without shaking (and in the absence of
amyloid seeds), we find that the presence of Ficoll70
(70–350 mg/mL tested) can trigger aS amyloid forma-
tion (Fig. S2). The presence of less than 140 mg/mL
Ficoll70 did not increase the ThT fluorescence, whereas
210 mg/mL was enough to obtain a completed aggregation
curve within 160 h. Interestingly, increasing the Ficoll70
concentration to 350 mg/mL did not decrease the lag time
as compared with aS samples containing 280 mg/mL
Ficoll70. We selected 140 and 280 mg/mL Ficoll70 as our
conditions for further studies as they span from the lower
to the higher end of the crowdedness in vivo (42). Both these
Ficoll70 concentrations trigger aggregation of aS monomers
within the time frame of the experiment (only partly for
140 mg/mL) (Fig. 1 A). The resulting amyloid fibers formed
at these conditions look like amyloids of aS formed in buffer
condition when analyzed by AFM (Fig. 1, B and C); Ficoll70
itself is too small to be visible by AFM, and only some aggre-
gates can be detected when analyzing Ficoll70 samples by
AFM (Fig. 1 D). The time to 50% change in ThT fluores-
cence (midpoint of transition) with 280 mg/mL Ficoll70 is
25 h, and the ThT fluorescence starts to rise at around
14–15 h. For the 140 mg/mL Ficoll70 condition, the ThT
fluorescence starts to rise at 50 h. If this is compared
with buffer conditions in which no ThT fluorescence change
is detected during 140 h, it implies that the overall aS aggre-
gation reaction in the presence of 280 mg/mL Ficoll is at
least 10-fold faster than in buffer. Likely, the accelerating
factor by 280 mg/mL Ficoll70 is larger than 10-fold because
a transition midpoint of 400 h was reported in another study
of aS aggregation in buffer (43). In that study, a 14 times
higher protein concentration was used (no shaking and beads,
no seeds, and high salt) compared with here. Notably, we
found a similar accelerating effect when including another
crowding agent, polyethylene glycol 35 (35 kDa), but the
addition of Ficoll’s building block, the small-molecule osmo-
lyte sucrose, which provides increased viscosity and solva-
tion effects but not increased excluded volume, had no
initiation of aS amyloid formation within 100 h (Fig. S3).Effect of Ficoll70 on primary nucleation
The accelerated aggregation curves in the presence of Ficoll
70 may be explained by excluded-volume effects on all or
some of the microscopic processes, with primary nucle-
ation, elongation, and secondary nucleation as most impor-
tant, that take place during amyloid formation. To test if the
presence of Ficoll70 accelerates aS primary nucleation, we
analyzed samples from aggregation reactions after 4 h of in-
cubation in buffer and 280 mg/mL Ficoll70 conditions. At
FIGURE 1 Effect of Ficoll70 on aS amyloid formation at quiescent conditions. (A) Amyloid formation kinetics (curves are averages of four individual
replicates) of aS in quiescent conditions as followed by ThT fluorescence in buffer (black) in the presence of 140 mg/mL (red) and in the presence of
280 mg/mL Ficoll70 (blue) (examples of individual traces shown in Fig. S6 A). (B) AFM of aS amyloid fibers formed in the presence of 280 mg/mL Ficoll70,
(C) AFM of aS amyloid fibers formed in buffer with agitation, and (D) AFM of 280 mg/mL Ficoll70 alone.
Crowding effects on amyloid kineticsthis time point, both curves remain flat with respect to ThT
signal; thus, it is a data point in the lag phase. AFM analysis
of these solutions showed that the Ficoll70 sample con-
tained spherical oligomers with sizes of 5–7 nm, whereas
no oligomers were found in the aS sample in buffer
(Fig. S4, A–C). Notably, the few aggregates sometimes de-
tected by AFM in Ficoll70-only solutions are larger
(>20 nm) and do not match the spherical species detected
in the presence of aS (Figs. 1 D and S4 D). CD analysis
of 4-h samples with crowding reveals that these aS assem-
blies have unstructured secondary structure (Fig. S4 E).
Therefore, these aS species are likely intermediates in the
primary nucleation step, which eventually convert to b-
structured seeds that can be elongated. Taken together, the
presence of the macromolecular crowding agent Ficoll70
accelerates the nonseeded (overall) aS amyloid formation
reaction, which appears to include enhancement of primary
nucleation because oligomers are detected at early time
points.Effect of Ficoll70 on amyloid fiber elongation
To specifically investigate aS amyloid fiber elongation, we
turned to fiber-seeded reactions using sonicated fiber seeds.
Sonication of preformed fibers gives shorter amyloid fibers,
thus with more ends to elongate (per concentration of aS
monomers) as compared with nonsonicated fibers. AFM
of sonicated seeds are shown in Fig. 2 D, and size analysis
gives an average seed length of200 nm (Fig. S5). In Fig. 2,
A–C, we show ThTaggregation data for aS-seeded reactions
at different concentrations of sonicated seeds comparing no
added Ficoll70 (i.e., buffer), 140- and 280-mg/mL Ficoll70
conditions. Examples of sets of replicate curves are shown
in Fig. S6 for both seeded and unseeded reactions, implying
high reproducibility. As expected for fiber-seeded aggrega-
tion reactions, the lag phase is bypassed, and elongation
starts immediately in these experiments. Fiber seed concen-
tration is given in molar percent of monomers present as fi-
ber seeds versus monomers free in solution. It is clear from
the data that fiber-seeded reactions are also accelerated by
the presence of Ficoll70, but the effect is not as extensive
as the effect on the nonseeded amyloid formation reaction(cf. Fig. 1 A). Whereas the kinetic traces at 20% fiber seed
all show hyperbolic shapes, at a lower percentage of seeds,
the kinetic traces in the crowded solutions appear biphasic
with a second phase that starts around 5–8 h of reaction.
Thus, the reaction mechanism differs between low and
high seed percentages. Two-phase behavior can be an indi-
cation of secondary processes taking over when enough
elongation has taken place (44) and will be discussed in
the next section.
To analyze the elongation process in a quantitative way,
we collected aggregation data for four amyloid seed concen-
trations at 0, 140, and 280 mg/mL Ficoll70 at a fixed aS
monomer concentration (Fig. 2, E–G). Analysis of the initial
rates (slope in the first 1–2 h, shown in Fig. S7) provides a
measure of the elongation rate at that condition. In Fig. 2 H,
we plot the initial rates versus amyloid fiber seed concentra-
tion for the three different conditions, and each data set is
fitted to a linear dependence. A linear dependence between
initial rates and seed concentrations is expected for pro-
cesses involving elongation (44). It is clear from the plot
that in the presence of crowding agent, initial rates are faster
at each seed concentration (by a factor of 2). Also, the
dependence of the initial rate on the seed concentration is
stronger (i.e., steeper slopes of fitted lines) with the presence
of crowding agent, although the 140- and 280-mg/mL Fi-
coll70 data are rather similar to each other. The increased
slope for crowded conditions means that each unit of new
fiber seed added will have a larger effect on the aggregation
kinetics when in a crowded condition. As another way to
showcase the difference between the conditions, to get the
same enhancing effect on elongation kinetics, one needs
to add 10% seeds in buffer but only 3–4% fiber seeds in
crowded conditions. This implies that in vivo, which is a
crowded condition, a small number of seeds will have a
larger effect on its surrounding polypeptides than what is
measured in buffer. We speculate this to be relevant for dis-
ease onset in patients. In agreement with our results, the sin-
gle existing publication that describes macromolecular
crowding effects on aS fiber elongation reported (using
quartz crystal microbalance experiments) that the elonga-
tion rate was increased by 1.8-fold in the presence of
50 mg/mL dextran (200 kDa) (45).Biophysical Journal 120, 3374–3381, August 17, 2021 3377
FIGURE 2 Effects of sonicated seeds on aS amyloid formation. Seeded amyloid formation kinetics with and without added Ficoll70 with 2.5 (A), 5 (B),
and 20% (C) preformed sonicated aS amyloid fibers. (D) AFM image of sonicated amyloid fibers used in the measurements. Shown are seeded aggregation
curves with various fiber seed concentrations in buffer (E), in 140 mg/mL (F), and in 280 mg/mL Ficoll70 (G). The traces in (A)–(C) are replotted in (E)–(G)
together with 10% seed data. All traces shown are representative individual traces. In Fig. S6, we show sets of individual traces for some different conditions
to illustrate the magnitude of variability in the kinetic data. (H) Plot of initial rates of fiber elongation, as determined by linear fitting of the first 1–2 h of the
reaction at each condition (Fig. S7 for examples of such data), versus molar percent seeds. Initial rates derived from individual experiments (between 9 and 12
for each condition) were then averaged and is here plotted with standard deviation. The average initial rate versus seed concentration (given as molar percent
monomers in added seeds versus monomers in solution) at each solution condition was fitted to a linear equation (solid lines). Monomeric aS concentration
was 50 mM in all experiments.
Horvath et al.For comparison, we performed similar aS amyloid fiber
(sonicated seeds) seeding experiments in the presence of su-
crose at a high concentration (Fig. S8). In contrast to in Fi-
coll70, we found seeded aS amyloid formation reactions in
the presence of sucrose to be slowed down as compared with
in buffer. The elongation rates were two to three times
slower with sucrose as compared with without. The viscos-
ity of 550 mg/mL sucrose (4 cP) match the bulk viscosity
of 140 mg/mL Ficoll70, but whereas the micro- and macro-
viscosities are the same in sucrose, for Ficoll70, the micro-
viscosity is lower than the bulk viscosity (46). In accord
with the sucrose effect on aS elongation here, we previously
showed that sucrose retarded amyloid fiber elongation ki-
netics of the amyloidogenic protein parvalbumin (47).Effect of Ficoll70 on secondary pathways
ThT kinetic data collected for amyloid-fiber-seeded reac-
tions within a time frame in which there is no detectable re-
action without added seed cannot include primary
nucleation but may involve secondary processes in addition
to elongation (48,49). Observation of biphasic behavior at
such conditions, in which there is a first phase (at early
time points) that transitions to another kinetic phase (at later
time points), in the ThT kinetics must include secondary
processes. In principle, when enough elongation has
occurred in a sample, secondary (faster) processes take
over the reaction (44). For aS aggregation, this behavior
may be favored in seeded reactions using nonsonicated
seeds for which the number of fiber ends are fewer than3378 Biophysical Journal 120, 3374–3381, August 17, 2021when adding sonicated seeds (cf. Fig. 2 D, sonicated seeds;
Fig. 3 D, nonsonicated seeds). Like with the sonicated seeds
(Fig. 2), the addition of nonsonicated seeds to aS mono-
meric samples removes the lag time at all conditions (buffer
and Ficoll70). In Fig. 3 A, for aS aggregation upon addition
of nonsonicated seeds in buffer, most kinetic curves are hy-
perbolic, indicating no secondary processes and only elon-
gation. However, at the lowest seed percentage (2.5%), a
tendency for biphasic behavior is noted in the kinetics trace.
In the presence of a crowding agent, 140 and 280 mg/mL Fi-
coll 70, the biphasic behavior is evident at all conditions
except at the highest seed percentage (20%; here, hyperbolic
curve) (Fig. 3, B and C). Inspection of Fig. 2, F and G shows
that also for sonicated fiber seeds at low concentrations, the
kinetic traces are biphasic in the presence of crowding
agent. Importantly, there are no primary nucleation within
140, 50, and 15 h for buffer, 140 and 280 mg/mL Ficoll70
conditions, respectively, based on Fig. 1 A. Thus, the ki-
netics detected are due to the added seeds only and, when
biphasic, must include an additional process in addition to
elongation. Secondary processes can involve secondary
nucleation, meaning new fibers are nucleated on the surface
of existing fibers, and fragmentation, meaning existing fi-
bers break forming new fiber ends that can be elongated
(48,49). The latter process (fragmentation) is likely not
important here because we have quiescent conditions.
According to closed-form analytical solutions to rate
equations for filament assembly via elongation and second-
ary pathways (50,51), a plot of the time to midpoint of tran-
sition versus the logarithm of the seed concentration should
FIGURE 3 Effects of nonsonicated seeds on aS amyloid formation. Shown is seeded aggregation with nonsonicated aS fibers in TBS (A), in 140 mg/mL
Ficoll 70 (B), and in 280 mg/mL Ficoll 70 (C). (D) AFM image of the nonsonicated fibers used in the measurements. (E) Plot of time to midpoint of ThT
transition versus the logarithm of seed concentration at different Ficoll70 concentrations (individual kinetic traces (~12 replicates) for each condition was
here averaged; average shown with standard deviation). The midpoints versus logarithm (seed concentration) for the two Ficoll70 conditions were fitted to
linear equations (excluding 20% seed data because it is not biphasic) shown as solid lines. For TBS, only the midpoint for 2.5% seeds is included because it is
the only curve that shows some content of secondary nucleation. Shown are the comparing aggregation curves in TBS, 140 and 280 mg/mL Ficoll70 at 2.5
(F), 5 (G), and 10% (H) nonsonicated seeds (kinetic curves from A–C panels are replotted). Monomeric aS concentration was 50 mM at each condition. All
aggregation curves shown in (A–C) and (F–H) are representative single measurements (each taken from 12 replicates collected at each condition).
Crowding effects on amyloid kineticsshow a linear dependency. As can be seen, such a depen-
dence appears reasonable for the crowded conditions
(Fig. 3 E). We therefore propose that the presence of macro-
molecular crowding promotes secondary processes during
aS aggregation at pH 7, quiescent conditions. Inspection
of Fig. 3 E reveals that the difference in midpoints between
the buffer (at 2.5% seeds, in which biphasic behavior is
observed; data point (black square) is next to the E label
in the panel) and crowded conditions, is around threefold,
i.e., secondary processes are accelerated by a factor 3 at
crowded conditions. AFM and far-UV CD analysis of aS
amyloid fibers formed in the presence of nonsonicated seeds
reveal no major differences in amyloid fiber morphology or
b-sheet secondary structure as compared with fibers formed
with sonicated fiber seeds in both buffer and Ficoll70
(Fig. S9).
Clear biphasic behavior, indicating contributions from
secondary nucleation, is also found in the seeded (sonicated
seeds) reactions in the presence of sucrose (Fig. S8). The un-
derlying reason for this stimulation of secondary processes
by both Ficoll70 and sucrose (although one agent speeds
up and the other slows down overall reaction) need further
investigation.
When the data with nonsonicated seeds are plotted at
fixed seed concentration versus crowding agent concentra-
tion variation, it emerges that the difference between 140
and 280 mg/mL Ficoll70 is small at each percent seed con-
dition (Fig. 3, F–H). This implies that the accelerating effect
on aS assembly kinetics approaches saturation at high Fi-
coll70 concentrations; this may be due to Ficoll70-induced
viscosity effects (slowing translational diffusion) counter-acting further excluded-volume-induced acceleration at
high Ficoll70 concentrations.CONCLUSIONS
We have here analyzed the effect of one macromolecular
crowding agent (Ficoll70) on individual steps involved in
aS amyloid formation kinetics at quiescent conditions using
seeding. We used 140 and 280 mg/mL Ficoll70 here, which
is comparable with the estimates of macromolecules in the
cytoplasm of cells that range between 5 and 400 mg/mL
(10,52). A recent study suggested that 150–200 mg/mL Fi-
coll70 match the condition in the cytoplasm with respect to
translational and rotational diffusion (42). Nonetheless,
whereas in vitro crowding experiments are homogeneous,
cellular conditions will be very heterogeneous. In accord
with the overall conclusions of earlier work (34–38), aS am-
yloid formation is accelerated in the presence of macromo-
lecular crowding agents in vitro. However, our approach
contrasts the earlier studies (34–38) that either used shaking
and bead conditions or quiescent conditions without seeds in
that it makes possible the analysis of individual processes.
From our collected results, we can conclude that primary
nucleation, fiber elongation as well as secondary nucleation
are accelerated by the macromolecular crowding agent
Ficoll70. Thus, introduction of excluded-volume results in
faster microscopic processes but no change of underlying
amyloid formation mechanism (Fig. 4).
Although quantification is difficult, the data suggest that
primary nucleation is more affected by macromolecular
crowding than elongation and secondary nucleation steps.Biophysical Journal 120, 3374–3381, August 17, 2021 3379
FIGURE 4 Illustration of macromolecular
crowding effects on aS amyloid formation as deter-
mined in this study using Ficoll70 as crowding
agent (pH 7; quiescent conditions). We note that
the acceleration factors (in red) are estimates.
Based on aggregation experiments without amyloid
seeds, the overall reaction is accelerated at least 10-
fold (Fig. 1 A). Concentration-dependent analysis
of elongation specifically (Fig. 2 H) reveals a
twofold increase with crowding agent; this implies
that primary nucleation must be accelerated at least
fivefold (to get a net effect that is larger than 10-
fold). Secondary nucleation is stimulated with Fi-
coll70 and at conditions in which this is seen in
part also in buffer (2.5% nonsonicated seeds
Fig. 3 E; typically, there is very little secondary
nucleation in buffer at neutral pH); the reaction is
3-fold faster in Ficoll70 than in buffer.
Horvath et al.This implies that the reduction of excluded volume is larger
for initial oligomer formation and nucleation than for the
addition of monomers to growing fiber ends. Nonetheless,
alterations of biochemical reactions by modest factors,
such as 2 or 3, may still have dramatic effects in vivo.
This study is only a first step to dissect macromolecular
crowding effects on amyloid fiber formation reactions.
Further studies including other crowding agents, mixtures
of crowding agents, and other amyloidogenic proteins are
required to reveal general features. Finally, a note of
caution. Our initial data using shaking in the presence of
glass beads suggest that such conditions are not appropriate
(because of viscosity effects on bead movement) for macro-
molecular crowding experiments.SUPPORTING MATERIAL
Supporting material can be found online at https://doi.org/10.1016/j.bpj.
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Figure S1: Aggregation of aS with agitation and glass beads in TBS (black), in the presence 
of 140 mg/mL (red) and 280 mg/mL Ficoll70 (blue) (A); quantification of soluble protein 
using SDS PAGE after amyloid formation reactions at agitation conditions (B, C); far-UV 
CD spectra of 5 µM aS in 10 mM pH 7.4 NaPi buffer (black), and in 140 mg/mL (red) or 280 
mg/mL Ficoll70 (blue) (D).  
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Figure S2: Aggregation of aS in quiescent conditions in the presence of various 
concentrations from 70 to 350 mg/mL of Ficoll70. aS concentration was 50 µM and each 







Figure S3: Aggregation of aS in quiescent conditions in the presence of 550 mg/mL sucrose 








Figure S4: A. aS incubated for 4 h in the presence of Ficoll70. B. Analysis of height 
distribution of oligomers based on AFM images (725 objects counted in 3 different images) 
C. aS incubated for 4 h without Ficoll70 (i.e., in TBS). D. Two typical AFM images of 
Ficoll70 alone, demonstrating the presence of large aggregates (>20 nm height) occasionally. 

























Figure S5: Length distribution of sonicated aS amyloid fiber seeds. Fibers were counted and 
quantified by the use of flooding analysis in the WSXM 5.0 software. 301 amyloid fibers 




Figure S6: Examples of 4 replicates for unseeded aggregation in 140 and 280 mg/mL Ficoll70 (A) 
and for seeded aggregation with sonicated fibers at various seed concentrations in TBS (B-E) and in 
140 mg/mL Ficoll70(F-I). Each graph shows 4 replicates in faded colors (grey, red, green and blue) 




Figure S7: Examples of initial rate determination  with linear fits for seeded aS aggregation using 
sonicated seeds (percent seeds given in the panels) in TBS (A) and in 140 mg/mL Ficoll70 (B).The 
fits are performed on normalized single measurements; the mean and standard deviation values shown 











Figure S8: Seeded amyloid formation kinetics for aS using sonicated seeds in 550 mg/mL 
sucrose (A) at different seed concentrations. Initial rates of the seeded aggregation reactions 







Figure S9: AFM images of aS fibers formed in TBS after seeded aggregation with non-
sonicated (A) or sonicated seeds (B) and in the presence of 280 mg/mL Ficoll70 after seeded 
aggregation with non-sonicated (C) or sonicated seeds (D). E. Far-UV CD of aS fibers after 
seeded aS aggregation using non sonicated seeds in TBS (black), sonicated seeds in TBS 
(red), non-sonicated seeds in the presence of Ficoll70 (blue), and sonicated seeds with 
Ficoll70 (green). For these far-UV CD spectra, the same aggregation reactions were 
performed as in Figures 2 and 3, but in the absence of ThT. After completed incubation in the 
plate reader, the samples were spun down (30 000g, 30 min) and the amyloid fiber pellets 
were resuspended in 10 mM phosphate buffer. Protein concentration was checked by 
absorption before CD analysis. 
   
 
